483
Joseph L. Lillo, D.O.FDA 483 - Joseph L. Lillo, D.O. - March 22, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Joseph L. Lillo, DO, Clinical Investigator, in Phoenix, AZ, from March 15-22, 2021, revealed significant deviations from clinical trial protocols. The investigator failed to conduct an investigation in accordance with the signed statement and investigational plan. Specifically, a subject meeting exclusion criteria was enrolled, and five adverse events were not reported to the sponsor.
Open in Dashboard
ID · d65fcd27-e80d-49f3-a8d7-c82d6fa4141f